Net sales were $77.4 million for the first quarter of 2024, up 5% compared to $73.5 million reported in the prior year quarter. Mon, jan 8, 2024, 7:00 am 6 min read.
Staar surgical (nasdaq:staa) first quarter 2024 results key financial results. First quarter 2024 financial results.
Staar Test Results For Texas Public School Students By District And Teacher Years Of Experience
Recorded a net loss of $3.3.
Staar Surgical (Nasdaq:staa) First Quarter 2024 Results Key Financial Results.
Commissioner reacts to houston isd protest.
Images References :
K), A Leading Developer, Manufacturer And Marketer Of The Evo Family Of Implantable Collamer® Lenses (Evo Icl™) For Myopia, Astigmatism And Presbyopia,.
“staar is off to a solid start in 2024 as illustrated by our preliminary first quarter results including a record quarter in the u.s.,” said tom frinzi, president and.
Early Student Results Are Available In Crs On This Date For All Educators.
Net sales were $77.4 million for the first quarter of 2024, up 5% compared to $73.5 million reported in the prior year quarter.
